| Nitroxyl (HNO): the Cinderella of the nitric oxide story JC Irvine, RH Ritchie, JL Favaloro, KL Andrews, RE Widdop, ... Trends in Pharmacological Sciences 29 (12), 601-608, 2008 | 301 | 2008 |
| NO− Activates Soluble Guanylate Cyclase and Kv Channels to Vasodilate Resistance Arteries JC Irvine, JL Favaloro, BK Kemp-Harper Hypertension 41 (6), 1301-1307, 2003 | 176 | 2003 |
| Impairment of both nitric oxide‐mediated and EDHF‐type relaxation in small mesenteric arteries from rats with streptozotocin‐induced diabetes CH Leo, JL Hart, OL Woodman British journal of pharmacology 162 (2), 365-377, 2011 | 132 | 2011 |
| Nitroxyl anion donor, Angeli’s salt, does not develop tolerance in rat isolated aortae JC Irvine, JL Favaloro, RE Widdop, BK Kemp-Harper Hypertension 49 (4), 885-892, 2007 | 127 | 2007 |
| A role for nitroxyl (HNO) as an endothelium‐derived relaxing and hyperpolarizing factor in resistance arteries KL Andrews, JC Irvine, M Tare, J Apostolopoulos, JL Favaloro, CR Triggle, ... British journal of pharmacology 157 (4), 540-550, 2009 | 126 | 2009 |
| The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature JL Favaloro, BK Kemp-Harper Cardiovascular research 73 (3), 587-596, 2007 | 125 | 2007 |
| Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice MR Al-Magableh, BK Kemp-Harper, JL Hart Hypertension Research 38 (1), 13-20, 2015 | 120 | 2015 |
| Mechanism of vasorelaxation and role of endogenous hydrogen sulfide production in mouse aorta MR Al-Magableh, JL Hart Naunyn-Schmiedeberg's archives of pharmacology 383, 403-413, 2011 | 102 | 2011 |
| Redox variants of NO (NO· and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms JL Favaloro, BK Kemp-Harper American Journal of Physiology-Heart and Circulatory Physiology 296 (5 …, 2009 | 77 | 2009 |
| Hydrogen sulfide as a vasculoprotective factor E Streeter, HH Ng, JL Hart Medical gas research 3, 1-7, 2013 | 68 | 2013 |
| Hydrogen sulfide protects endothelial nitric oxide function under conditions of acute oxidative stress in vitro. MR Al-Magableh, BK Kemp-Harper, HH Ng, AA Miller, JL Hart Naunyn-Schmiedeberg's archives of pharmacology 387, 67-74, 2014 | 67 | 2014 |
| An investigation of the mechanisms of hydrogen sulfide-induced vasorelaxation in rat middle cerebral arteries E Streeter, J Hart, E Badoer Naunyn-Schmiedeberg's archives of pharmacology 385, 991-1002, 2012 | 59 | 2012 |
| Interdisciplinary project-based learning as a means of developing employability skills in undergraduate science degree programs J Hart Journal of Teaching and Learning for Graduate Employability 10 (2), 50-66, 2019 | 58 | 2019 |
| 3′, 4′-Dihydroxyflavonol reduces superoxide and improves nitric oxide function in diabetic rat mesenteric arteries CH Leo, JL Hart, OL Woodman PLoS One 6 (6), e20813, 2011 | 54 | 2011 |
| Role of sulfur-containing gaseous substances in the cardiovascular system JL Hart Front Biosci (Elite Ed) 3 (2), 736-49, 2011 | 49 | 2011 |
| Endothelium-dependent nitroxyl-mediated relaxation is resistant to superoxide anion scavenging and preserved in diabetic rat aorta CH Leo, A Joshi, JL Hart, OL Woodman Pharmacological research 66 (5), 383-391, 2012 | 42 | 2012 |
| Chronic NaHS treatment decreases oxidative stress and improves endothelial function in diabetic mice HH Ng, GS Yildiz, JM Ku, AA Miller, OL Woodman, JL Hart Diabetes and Vascular Disease Research 14 (3), 246-253, 2017 | 37 | 2017 |
| 3′, 4′-Dihydroxyflavonol restores endothelium-dependent relaxation in small mesenteric artery from rats with type 1 and type 2 diabetes CH Leo, JL Hart, OL Woodman European journal of pharmacology 659 (2-3), 193-198, 2011 | 31 | 2011 |
| An evaluation of pharmacology curricula in Australian science and health-related degree programs H Lloyd, T Hinton, S Bullock, AM Babey, E Davis, L Fernandes, J Hart, ... BMC Medical Education 13, 1-15, 2013 | 29 | 2013 |
| Chronic NaHS treatment is vasoprotective in high-fat-fed ApoE−/− mice A Ford, M Al-Magableh, TA Gaspari, JL Hart International journal of vascular medicine 2013, 2013 | 25 | 2013 |
